A detailed history of Sittner & Nelson, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Sittner & Nelson, LLC holds 75 shares of EXAS stock, worth $4,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 75 -0.0%
Holding current value
$4,202
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$59.06 - $75.72 $8,859 - $11,358
-150 Reduced 66.67%
75 $5,000
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $2,397 - $3,702
-75 Reduced 25.0%
225 $7,000
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $2,670 - $5,717
75 Added 33.33%
300 $12,000
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $18,732 - $27,854
200 Added 800.0%
225 $28,000
Q1 2021

May 06, 2021

BUY
$116.57 - $155.01 $2,914 - $3,875
25 New
25 $3,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.